日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and molecular determinants of response to maintenance olaparib for primary and recurrent epithelial ovarian carcinoma

原发性和复发性上皮性卵巢癌维持治疗奥拉帕尼疗效的临床和分子决定因素

Wagar, Matthew K; Bharucha, Kharmen; Montemorano, Lauren; Huffman, Laura B; Godecker, Amy L; Barroilhet, Lisa M

Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial Cancer

每日服用依西美坦治疗子宫内膜上皮内瘤变或低级别子宫内膜癌女性患者的初步研究

Erickson, Britt K; Bailey, Howard; Arend, Rebecca C; El-Rayes, Dina; Khalifa, Mahmoud A; Skubitz, Amy; Boylan, Kristin; Nelson, Andrew C; Burton, Anna; Thyagarajan, Bharat; Havighurst, Thomas; Kim, KyungMann; Dimond, Eileen; DeShong, Katina; Heckman-Stoddard, Brandy; Samimi, Goli; Szabo, Eva; Barroilhet, Lisa

Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinoma.

GATA2 的缺失会促进侵袭,并预测子宫浆液性癌的复发和生存

Polaki Usha S, Gilpin Trey E, Patil Apoorva T, Chiu Emily, Baker Ruth, Liu Peng, Pavletich Tatiana S, Seifi Morteza, Mañán-Mejías Paula M, Morrissey Jordan, Port Jenna, Welch Schwartz Rene, Ong Irene M, El-Rayes Dina, Khalifa Mahmoud A, Hui Pei, Horner Vanessa L, Virumbrales-Muñoz María, Erickson Britt K, Barroilhet Lisa, McGregor Stephanie M, Bresnick Emery H, Matson Daniel R

Antidepressant Remission and Manic Switch in Bipolar Depression: A Propensity Score Analysis

双相抑郁症抗抑郁缓解与躁狂转换:倾向评分分析

Vöhringer, Paul A; Barroilhet, Sergio A; Palma, Bárbara A; Perlis, Roy H

Early Detection and Prevention of Ovarian Cancer

卵巢癌的早期发现和预防

Montemorano, Lauren; Huffman, Laura; Barroilhet, Lisa

Atovaquone-induced oxidative stress activates the pentose phosphate pathway and Immunogenic cell death in ovarian cancer

阿托伐醌诱导的氧化应激激活磷酸戊糖途径,并导致卵巢癌细胞发生免疫原性死亡。

Mayra Betancourt Ponce ,Nicha Boonpattrawong ,Alexander J Fagan ,Michael Newton ,Manish Patankar ,Lisa Barroilhet

SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression.

SM08502 介导的 β-catenin 抑制与奥拉帕尼协同作用抑制肿瘤进展。

Corr Bradley R, Woodruff Elizabeth R, Yamamoto Tomomi M, Jordan Kimberly R, Danhorn Thomas, Bossard Carine, Nguyen Lily L, Chuong Edward B, Wick Lars, Young Alexandra, Kusumoto Shinya, Orsulic Sandra, Barroilhet Lisa, Bitler Benjamin G

Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery

膀胱癌手术前每周服用厄洛替尼的II期临床化学预防试验

Downs, Tracy M; Bailey, Howard H; Lozar, Taja; Schmitz, Natalie S; Green, Heather; Scarlett, Cameron O; Havighurst, Thomas C; Twaroski, Kyleigh; DeShong, Katina; Wollmer, Barbara; Bivalacqua, Trinity J; Saltzstein, Daniel R; Shore, Neal; Kim, KyungMann; Huang, Wei; Ricke, William A; Barroilhet, Lisa; House, Margaret; Parnes, Howard L; Messing, Edward

Data mining of PubChem bioassay records reveals diverse OXPHOS inhibitory chemotypes as potential therapeutic agents against ovarian cancer

PubChem 生物测定记录的数据挖掘揭示了多种 OXPHOS 抑制化学型作为卵巢癌的潜在治疗剂

Sejal Sharma, Liping Feng, Nicha Boonpattrawong, Arvinder Kapur, Lisa Barroilhet, Manish S Patankar, Spencer S Ericksen

Editorial on vaginal cancer diagnosed in pregnancy and current abortion law on cancer care in Louisiana

关于路易斯安那州妊娠期诊断阴道癌及现行堕胎法对癌症治疗影响的社论

Barroilhet, Lisa